Asthma and Copd
April 2 - 3, 2014 - Marriott Regents Park Hotel, London NW3 3ST UK
SMi Group Ltd
fbegum@smi-online.co.uk
Phone: 44 020 7827 6184
The global market for Asthma and COPD drugs is set to reach $47bn in 2017. There is a growing demand for the next generation of inhaled combination products and novel therapeutics. Asthma and COPD 2014 will enable delegates to gain valuable insights into the latest ground-breaking advances in the respiratory drug market. It will focus on the challenges and strategies to enhance patient outcomes, providing extensive knowledge from the key leading industry and academic experts.